Valuation check: IRTC's profit margin is -1.69%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for IRTC is -1.69% as of June 2026. That compares with -14.06% in the prior-year period — up 88.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside iRhythm Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, IRTC's profit margin moved from -14.06% to -1.69% — a 88.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in iRhythm Technologies's valuation or profitability profile.
Against Healthcare companies, IRTC currently prints -1.69% for profit margin, while the sector average sits near 14.34%. That is roughly 111.8% below the sector mean. Large gaps often invite a closer look at iRhythm Technologies's growth, margins, and balance sheet.
Profit Margin shows how effectively iRhythm Technologies converts resources into returns. At -1.69%, IRTC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -14.06% in the prior-year period — up 88.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting IRTC's profit margin (-1.69%), review year-over-year change from -14.06%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.